Reed Jobs on Founding Yosemite and the New Age of Biology

Transforming cancer from a lethal diagnosis into a manageable, chronic condition requires shifting the focus from elusive "cures" to long-term patient survival and quality of life. Reed Jobs, founder of Yosemite, advocates for a model that integrates philanthropy with venture capital to de-risk early-stage scientific research. By using grants to test hypotheses before commercialization, this approach mirrors the efficiency of startup accelerators, allowing researchers to focus on innovation rather than administrative fundraising. Key advancements include the application of AI to optimize clinical trials through synthetic control arms and the development of CAR T-cell therapies for solid tumors. This strategy emphasizes the necessity of leveraging existing academic infrastructure and adapting to the evolving biotech landscape, where AI-driven tools accelerate drug discovery and improve the efficiency of complex, highly regulated medical development processes.